Financhill
Back

Innate Pharma SA Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
10

IPHA
Innate Pharma SA

Last Price:
1.82
Seasonality Move:
9.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Innate Pharma SA Price Quote

$1.82
+0.04 (+-2.93%)
(Updated: November 6, 2024 at 5:14 AM ET)

Innate Pharma SA Key Stats

Sell
10
Innate Pharma SA (IPHA) is a Sell

Day range:
$1.73 - $1.78
52-week range:
$1.70 - $3.15
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.37
P/B ratio:
4.67%

Volume:
4K
Avg. volume:
11.4K
1-year change:
-32.58%
Market cap:
$144.1M
Revenue:
$56.2M
EPS:
$-0.45

How Much Does Innate Pharma SA Make?

Is Innate Pharma SA Growing As A Company?

Data Unavailable

Innate Pharma SA Stock Price Performance

  • Did Innate Pharma SA Stock Go Up Last Month?
    Innate Pharma SA share price went down by -17.91% last month
  • Did IPHA's Share Price Rise Over The Last Year?
    IPHA share price fell by -32.58% over the past 1 year

What Is Innate Pharma SA 52-Week High & Low?

Innate Pharma SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Innate Pharma SA?

  • How Much Debt Does Innate Pharma SA Have?
    Total long term debt quarterly is $38.1M
  • How Much Cash Does Innate Pharma SA Have?
    Cash and short term investments quarterly total is $98.4M
  • What Is Innate Pharma SA’s Book Value Per Share?
    Book value per share is 0.38

Is Innate Pharma SA Cash Flow Positive?

  • What Is IPHA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.4M
  • What Is Innate Pharma SA’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.4M
  • What Is Innate Pharma SA’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $23.5M

Innate Pharma SA Return On Invested Capital

  • Is Management Doing A Good Job?
    IPHA return on invested capital is -39.78%
  • What Is Innate Pharma SA Return On Assets?
    ROA measures how assets are converting to revenues and is -18.89%
  • What Is IPHA Return On Equity?
    ROE is a measure of profitability and is -72.79%

Innate Pharma SA Earnings Date & Stock Price

Innate Pharma SA Competitors

Innate Pharma SA Dividend Yield

Innate Pharma SA Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.40
Upside from Last Price: 315.73%

Major Shareholders

  • How many IPHA shares are owned by institutional investors?
    351.4K IPHA shares are owned by institutional investors
  • How many IPHA shares are owned by insiders?
    0 IPHA shares are owned by insiders